Thema
6804DJ8Z9U
24
Capecitabine
Clinical Trial, Phase III
24
Journal Article
24
Randomized Controlled Trial
22
Research Support, Non-U.S. Gov't
18
0W860991D6
17
Deoxycytidine
17
Fluorouracil
17
U3P01618RT
17
Multicenter Study
13
Leucovorin
11
Q573I9DVLP
11
Comparative Study
10
Organoplatinum Compounds
10
Oxaloacetates
6
04ZR38536J
5
2S9ZZM9Q9V
5
Antibodies, Monoclonal, Humanized
5
Bevacizumab
5
Camptothecin
5
Oxaliplatin
5
XT3Z54Z28A
5
7673326042
4
Cetuximab
4
Irinotecan
4
PQX0D8J21J
4
Quinazolines
4
Biomarkers, Tumor
3
EC 2.7.10.1
3
3Z8479ZZ5X
2
50SG953SK6
2
Antibodies, Monoclonal
2
Antimetabolites, Antineoplastic
2
Cisplatin
2
Klinische Studie
2
DA87705X9K
2
Epirubicin
2
ErbB Receptors
2
Erlotinib Hydrochloride
2
Gemcitabine
2
Mitomycin
2
Protein Kinase Inhibitors
2
Q20Q21Q62J
2
0VUA21238F
1
AGG2FN16EV
1
Angiogenesis Inhibitors
1
Antineoplastic Agents
1
Antineoplastic Agents, Phytogenic
1
Biomarkers
1
mehr ...